Inari Medical, Inc. (NARI) Tops Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/02/23
Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism PatientsGlobeNewsWire • 05/22/23
Wall Street Analysts Think Inari Medical, Inc. (NARI) Could Surge 27.7%: Read This Before Placing a BetZacks Investment Research • 05/15/23
FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever SystemGlobeNewsWire • 03/06/23
Inari Medical, Inc. (NARI) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 02/27/23
Analysts Estimate Inari Medical, Inc. (NARI) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 02/20/23